2016 Ophthalmic Deals Book: Venture Funding, Commercial Equity, and Business/Technology Sales
This report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market. The information covers investments in ophthalmic ventures during 2016, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings.
ABOUT THE AUTHOR
We identified 53 transactions for 46 companies in 2016 that included investments to fund development of new ophthalmic products and technologies, commercialization of new products, or outright purchases of products or technologies. These transactions ranged from $1 million to $4.3 billion.
Our Report is Organized into Key Areas and Includes:
Companies Raising Funds
- New Venture Capital
- Commercial Equity
- Acquisition funds
Companies Making Investments
- Private Equity
- Strategic Investor
- Public Offering
68 Companies are Profiled in This Report
VIEW THE TABLE OF CONTENTS FOR THIS REPORT
Our report is the leading industry source for accurate and relevant information on all aspects of the mergers, acquisitions, and financing that occurred in 2016. It includes a comprehensive overview of the ophthalmic deals by sector and company. We cover venture funding, public offerings, and strategic purchases made during 2015 and 2016 and provide an outlook for 2017. The report also includes a comprehensive overview of the development pathway and market opportunity for each company.
This edition of our 2016 Ophthalmic Deals Book: Venture Funding, Commercial Equity, and Business/Technology Sales was released in February 2017. The report is printed in color and spiral bound for easy reading. The price of the report is $3,500 for a SINGLE USER LICENSE or $10,500 for an ENTERPRISE LICENSE. An electronic PDF copy and/or an additional paper copy is available for use within your company for an additional $500 and $300, respectively.